- Home
- OBIO vs PAYS Comparison
OBIO vs PAYS Comparison
Compare OBIO & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- PAYS
- Stock Information
- Founded
- OBIO 2017
- PAYS 2001
- Country
- OBIO United States
- PAYS United States
- Employees
- OBIO N/A
- PAYS N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- PAYS Business Services
- Sector
- OBIO Health Care
- PAYS Consumer Discretionary
- Exchange
- OBIO Nasdaq
- PAYS Nasdaq
- Market Cap
- OBIO 124.9M
- PAYS 125.2M
- IPO Year
- OBIO N/A
- PAYS 1998
- Fundamental
- Price
- OBIO $3.01
- PAYS $5.45
- Analyst Decision
- OBIO Strong Buy
- PAYS Strong Buy
- Analyst Count
- OBIO 5
- PAYS 4
- Target Price
- OBIO $14.20
- PAYS $6.56
- AVG Volume (30 Days)
- OBIO 236.8K
- PAYS 482.1K
- Earning Date
- OBIO 08-11-2025
- PAYS 07-30-2025
- Dividend Yield
- OBIO N/A
- PAYS N/A
- EPS Growth
- OBIO N/A
- PAYS N/A
- EPS
- OBIO N/A
- PAYS 0.11
- Revenue
- OBIO $2,886,000.00
- PAYS $63,792,627.00
- Revenue This Year
- OBIO $20.47
- PAYS $30.03
- Revenue Next Year
- OBIO $11.45
- PAYS $20.14
- P/E Ratio
- OBIO N/A
- PAYS $50.02
- Revenue Growth
- OBIO 30.23
- PAYS 26.77
- 52 Week Low
- OBIO $2.37
- PAYS $1.80
- 52 Week High
- OBIO $8.87
- PAYS $5.59
- Technical
- Relative Strength Index (RSI)
- OBIO 47.82
- PAYS 77.72
- Support Level
- OBIO $2.91
- PAYS $4.72
- Resistance Level
- OBIO $3.48
- PAYS $5.10
- Average True Range (ATR)
- OBIO 0.26
- PAYS 0.27
- MACD
- OBIO -0.01
- PAYS 0.00
- Stochastic Oscillator
- OBIO 28.78
- PAYS 91.18
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.